PYPD PolyPid Ltd. Ordinary Shares Surgical & Medical Instruments & Apparatus Best Medical Devices Stocks 2026 →

PolyPid Ltd. Ordinary Shares (PYPD) Stock: Buy, Sell, or Hold?

$6.45
+0.30 (+4.88%) ▲
5d: +2.22% 30d: +32.17% 90d: +28.74%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
31/100
Position
EXTENDED
30-Day Fair Range
$4.88 – $5.89
Position: EXTENDED
Forward P/E & Valuation
-6.5x
Next 12M consensus est.
Wall Street Target
$11.50
+87.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.32 / $7.15
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PYPD shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When PYPD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: PYPD is currently trading at $6.45, which is considered extended relative to its 30-day fair value range of $4.88 to $5.89.

Technical Outlook: Technically, PYPD is in a uptrend. Immediate support is located at $5.32, while resistance sits at $7.15. The stock is showing strong short-term momentum, up 4.9% recently.

Market Sentiment: PYPD scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.50 (+87.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $4.88 - $5.89
Company Quality Score 31/100 (SELL)
Volume Confirmation HIGH
Confidence Score 26.3%

Trading Range & Key Levels

30-Day Trading Range $4.88 - $5.89
Current vs Trading Range EXTENDED
Support Level $5.32
Resistance Level $7.15
Current Trend Uptrend
Technical data as of Nov 16, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKOUT
Days in Phase: 40d (70% conf)
Technical Setup Structure MONITORING
Absorption: Inactive (CMF 0.15)
Pullback / Drawdown: -6.8% from 52W High
Consolidation: Trending (ADX 23.8)

Quantitative Signal Breakdown

  • BEARISH: Price extended above range (+9.5% above its trading range)
  • BEARISH: Weak technical setup (0/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.9%)
  • BULLISH: Trading 87.0% below Wall St target ($11.50)
  • WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -6.53
Wall Street Target $11.50 (+87.0%)
Share PYPD Analysis

Share this live PYPD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PYPD)

Bullish 4 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 15, 2026
Daily AI digest
AI Retail Discussion Summary: Traders on StockTwits express bullish sentiment towards $PYPD, anticipating FDA approval and potential stock price increase. No new news articles were found.
Key Retail Themes: FDA approval Price increase
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 1:48 PM ET
Data refreshes hourly during market hours. Next update: 2:48 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PYPD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CYTK
Cytokinetics Inc
STRONG BUY
22 analysts
$109 57 HOLD
INSM
Insmed Inc
STRONG BUY
24 analysts
$194 34 SELL
MDGL
Madrigal Pharmaceuticals…
STRONG BUY
19 analysts
$689 44 HOLD
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$86 46 HOLD
IMNM
Immunome Inc
STRONG BUY
17 analysts
$35 44 HOLD
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals